@misc{indiciaeb4deedb530d5,
  title = {A novel bacterial protease inhibitor adjuvant in RBD-based COVID-19 vaccine formulations increases neutralizing antibodies, specific germinal center B cells and confers protection against SARS-CoV-2 infection.},
  author = {Coria, L. M. and Saposnik, L. M. and Pueblas Castro, C. and Castro, E. F. and Bruno, L. A. and Stone, W. B. and Perez, P. S. and Darriba, M. L. and Chemes, L. B. and Alcain, J. and Mazzitelli, I. and Varese, A. and Salvatori, M. and Auguste, A. J. and Alvarez, D. E. and Pasquevich, K. A. and Cassataro, J.},
  year = {2021},
  doi = {10.1101/2021.12.07.471590},
  url = {https://www.biorxiv.org/content/10.1101/2021.12.07.471590v1},
  note = {Source identifier: 10.1101/2021.12.07.471590}
}